Autopsy report · NCT01489722
Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients
Cause of deathNo reason given
Life of this trial
- Registered 3 months before it started.
- Ran for about 2 years 3 months before it stopped.
- 55 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Acute Myeloid Leukemia
- Interventions
- AZD1208
- Participants
- 55
- Sites
- 4
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.